HYLORIS PHARMACEUTICALS SA (HYL.BR) Stock Cash Flow
EBR:HYL - Euronext Brussels - BE0974363955 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.34M | -15.76M | -10.77M | -11.58M | -7.14M | |||
| Depreciation Amortization | 648.00K | 349.00K | 196.00K | 137.00K | 581.00K | |||
| Change In Working Capital | -1.42M | 2.18M | -1.98M | -577.00K | 101.00K | |||
| Interest Paid | N/A | N/A | 1.88M | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | 315.00K | N/A | N/A | |||
| Other non cash items | 206.00K | 41.00K | 666.00K | 769.00K | 1.89M | |||
| OPERATING CASH FLOW | -6.90M | -12.81M | -13.02M | -11.25M | -4.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -297.00K | -750.00K | -739.00K | -1.06M | -623.00K | |||
| Other Investing Activity | 556.00K | 10.64M | -10.63M | -2.01M | -10.00K | |||
| INVESTING CASH FLOW | 259.00K | 9.89M | -11.37M | -3.08M | -633.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -168.00K | -119.00K | -7.46M | -62.00K | -4.85M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 2.83M | N/A | N/A | |||
| Other Financing Activity | 0.00 | -12.00K | 12.46M | N/A | 74.25M | |||
| FINANCING CASH FLOW | -168.00K | -131.00K | 7.84M | -62.00K | 69.40M | |||
| CHANGE IN CASH | -6.81M | -3.05M | -16.55M | -14.39M | 64.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.90M | -12.81M | -13.02M | -11.25M | -4.57M | |||
| Capital Expenditure | -297.00K | -750.00K | -739.00K | -1.06M | -623.00K | |||
| FREE CASH FLOW | -7.20M | -13.56M | -13.76M | -12.31M | -5.19M | |||
All data in EUR